Dysregulation of the motility of the gastrointestinal tract in diabetic patients is a significant cause of morbidity. The molecular and cellular bases, much less an effective therapeutic management of this disorder, have yet to be identified. The overarching objective of this Program Project is to promote, facilitate and conduct basic, clinical and translational research on the causes of motility disorders with the ultimate goal to identify novel therapeutic treatments. Accordingly, this Program Project is broad, transdisciplinary and interdisciplinary and multidepartmental, but highly focused on the enteric system. The scientific objectives are met through three highly integrated projects that include 8 specific aims, and two cores. The investigators in this application are drawn not only from gastroenterology and physiology but also from neurology, immunology, radiology, surgery and quantitative imaging sciences. Project I (Pathobiology of Diabetic Gastroenteropathy) will study the role of the nNOS and HO/CO pathways in regulating ICC biology. Dysregulation of these pathways results in diabetic gastroenteropathy. Project 2 (Autoimmune and Diabetic Dysmotility) focuses on the role of neuronal autoimmunity as a cause of enteric neuropathy and dysmotility in diabetes. Project 3 (Neurohumoral Regulation in Diabetic Enteropathy) will evaluate a novel integrated neurohumoral axis comprising the incretin, GLP-1, disordered nitrergic neurotransmission and sympathetic dysfunction in diabetic neuropathy in humans. The Administrative Core A will provide leadership and integration of all Program Project activities. The Imaging Core B will provide a centralized resource for storing and sharing image data between projects, will provide advanced software for rigorous quantitative analysis, and will develop new methods for dynamic 3D imaging and image fusion. Through these projects and cores, this highly-interactive program will make significant progress toward understanding the pathobiology of the enteric system in diabetes and translate this knowledge into new diagnostic tools and therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
1P01DK068055-01
Application #
6811946
Study Section
Special Emphasis Panel (ZDK1-GRB-9 (M2))
Program Officer
Hamilton, Frank A
Project Start
2004-09-30
Project End
2009-06-30
Budget Start
2004-09-30
Budget End
2005-06-30
Support Year
1
Fiscal Year
2004
Total Cost
$1,246,443
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Cipriani, Gianluca; Gibbons, Simon J; Miller, Katie E et al. (2018) Change in Populations of Macrophages Promotes Development of Delayed Gastric Emptying in Mice. Gastroenterology 154:2122-2136.e12
Desai, A; O'Connor, M; Neja, B et al. (2018) Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms. Neurogastroenterol Motil 30:e13365
Miller, K E; Bajzer, Ž; Hein, S S et al. (2018) High temporal resolution gastric emptying breath tests in mice. Neurogastroenterol Motil :e13333
Karakashev, Sergey; Zhu, Hengrui; Wu, Shuai et al. (2018) CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity. Nat Commun 9:631
Rajan, Elizabeth; Al-Bawardy, Badr; Gostout, Christopher J et al. (2018) Endoscopic muscle biopsy sampling of the duodenum and rectum: a pilot survival study in a porcine model to detect myenteric neurons. Gastrointest Endosc 87:600-606
Zhong, Jian; Ye, Zhenqing; Lenz, Samuel W et al. (2017) Purification of nanogram-range immunoprecipitated DNA in ChIP-seq application. BMC Genomics 18:985
Parthasarathy, Gopanandan; Kudva, Yogish C; Low, Phillip A et al. (2017) Relationship Between Gastric Emptying and Diurnal Glycemic Control in Type 1 Diabetes Mellitus: A Randomized Trial. J Clin Endocrinol Metab 102:398-406
Gibbons, Simon J; Grover, Madhusudan; Choi, Kyoung Moo et al. (2017) Repeat polymorphisms in the Homo sapiens heme oxygenase-1 gene in diabetic and idiopathic gastroparesis. PLoS One 12:e0187772
Hayashi, Yujiro; Toyomasu, Yoshitaka; Saravanaperumal, Siva Arumugam et al. (2017) Hyperglycemia Increases Interstitial Cells of Cajal via MAPK1 and MAPK3 Signaling to ETV1 and KIT, Leading to Rapid Gastric Emptying. Gastroenterology 153:521-535.e20
Camilleri, Michael; McCallum, Richard W; Tack, Jan et al. (2017) Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study. Gastroenterology 153:1240-1250.e2

Showing the most recent 10 out of 134 publications